>Title;Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles.
>Date;21/8/2008
>Journal;J Neurosci Res
>Conflict;NA
